|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$1.02B
|
+$5.54M
|
+49,865
|
+0.4%
|
|
|
2
|
Wellington Management Group
Boston,
Massachusetts
|
$830M
|
+$78.9M
|
+710,086
|
+7%
|
|
|
3
|
Vanguard Group
Malvern,
Pennsylvania
|
$372M
|
+$10.2M
|
+91,515
|
+2%
|
|
|
4
|
Capital World Investors
Los Angeles,
California
|
$156M
|
-$12.6M
|
-113,000
|
-5%
|
|
|
5
|
|
$154M
|
+$10.7M
|
+96,271
|
+5%
|
|
|
6
|
BlackRock Fund Advisors
San Francisco,
California
|
$153M
|
+$13.5M
|
+121,946
|
+7%
|
|
|
7
|
BlackRock Institutional Trust
San Francisco,
California
|
$142M
|
+$1.01M
|
+9,049
|
+0.5%
|
|
|
8
|
First Trust Advisors
Wheaton,
Illinois
|
$126M
|
+$727K
|
+6,547
|
+0.4%
|
|
|
9
|
State Street
Boston,
Massachusetts
|
$124M
|
+$9.04M
|
+81,342
|
+6%
|
|
|
10
|
Gilder Gagnon Howe & Co
New York
|
$120M
|
-$1.38M
|
-12,391
|
-0.8%
|
|
|
11
|
Jennison Associates
New York
|
$119M
|
+$58.7M
|
+528,598
|
+55%
|
|
|
12
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$106M
|
-$43.5M
|
-391,099
|
-23%
|
|
|
13
|
|
$97.4M
|
-$9.44M
|
-84,961
|
-7%
|
|
|
14
|
BB Biotech
Schaffhausen,
Switzerland
|
$91M
|
+$18.6M
|
+167,000
|
+17%
|
|
|
15
|
Blue Ridge Capital
New York
|
$86.4M
|
–
|
–
|
–
|
|
|
16
|
Franklin Resources
San Mateo,
California
|
$75.4M
|
-$7.93M
|
-71,372
|
-7%
|
|
|
17
|
Wells Fargo
San Francisco,
California
|
$62.4M
|
+$4.69M
|
+42,219
|
+6%
|
|
|
18
|
Bridger Management
New York
|
$57.2M
|
+$9.83M
|
+88,509
|
+14%
|
|
|
19
|
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$57M
|
-$9.17M
|
-82,500
|
-10%
|
|
|
20
|
|
$53.4M
|
+$10.1M
|
+91,048
|
+16%
|
|
|
21
|
12 West Capital Management
New York
|
$52.3M
|
–
|
–
|
–
|
|
|
22
|
Amundi Asset Management US
Boston,
Massachusetts
|
$50.8M
|
+$285K
|
+2,569
|
+0.4%
|
|
|
23
|
Slate Path Capital
New York
|
$47.8M
|
-$9.64M
|
-86,759
|
-13%
|
|
|
24
|
|
$42.9M
|
+$13.6M
|
+122,644
|
+30%
|
|
|
25
|
|
$42.9M
|
-$19.3M
|
-173,966
|
-25%
|
|
